Sanofi Pasteur, the manufacturer of Stamaril yellow fever vaccine, have updated their Summary of Product Characteristics (SmPC), stating that the tip caps of Stamaril prefilled syringes contain a natural rubber latex derivative, which may cause allergic reactions in individuals sensitive to latex. As a result, healthcare professionals are reminded that they must take an accurate medical history and complete a risk assessment before administering any vaccine.
The following should be noted:
- Yellow fever vaccine can only be administered in designated yellow fever centres.
- Stamaril is the only yellow fever vaccine currently available in the UK.
- The manufacturer’s patient leaflet should be given to everyone receiving a yellow fever vaccine as part of their travel consultation.
Travellers considering yellow fever vaccination are advised to consult the yellow fever disease and vaccination pages on the fitfortravel website.
Source: TRAVAX, 22 December 2020